NCT04542031View on ClinicalTrials.gov

COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL

NACompletedINTERVENTIONAL
Enrollment

1,010

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Covid19Rheumatic Diseases
Interventions
OTHER

Questionnaire

Questionnaire to be completed at 6 and 12 months

Trial Locations (1)

WV10 0QP

The Royal Wolverhampton NHS Trust, Wolverhampton

All Listed Sponsors
lead

The Royal Wolverhampton Hospitals NHS Trust

OTHER_GOV

NCT04542031 - COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL | Biotech Hunter | Biotech Hunter